Literature DB >> 11843295

Establishment of a monosomy 7 leukemia cell line, MONO-7, with a ras gene mutation.

Hiroyuki Fujisaki1, Kenji Takai, Sawada Akihisa, Sadao Tokimasa, Yoshiko Matsuda, Hideaki Ohta, Yuko Osugi, Ji Yoo Kim, Gaku Hosoi, Masahiro Sako, Junichi Hara.   

Abstract

A monosomy 7 leukemia cell line, designated MONO-7, was established from the peripheral blood of a patient with monosomy 7 acute myelocytic leukemia (French-American-British classification M0). The cells were cultured continuously for more than 24 months in RPMI-1640 medium supplemented with 10% heat-inactivated fetal calf serum. The cell line exhibits an unclassified appearance. Cytochemically, alpha-naphthol-acetate esterase and myeloperoxidase are negative. Immunophenotypically, the cell line expresses CD33, CD13, CD56, CD34, CD38, HLA-DR, and CD45, but lacks T and B cell-associated antigens. Karyotypic analysis of the cell line showed only 45,XY,-7. Analysis of the N-ras gene mutation demonstrated identical mutations in fresh leukemic cells and the MONO-7 cell line. Clonal rearrangements of the immunoglobulin heavy-chain gene, T-cell receptor beta-chain gene, or T-cell receptor gamma-chain gene were not found in DNA extracted from MONO-7 cells. The growth of MONO-7 cells in vitro was stimulated by recombinant human granulocyte-macrophage colony-stimulating factor or interleukin 3. To our knowledge, this is the first report of the establishment of a cell line with the karyotype 45,XY,-7 without any other abnormality and with a ras gene mutation.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11843295

Source DB:  PubMed          Journal:  Int J Hematol        ISSN: 0925-5710            Impact factor:   2.490


  26 in total

1.  Prognostic impact of cytogenetic abnormalities in patients with de novo acute nonlymphocytic leukemia.

Authors:  C A Schiffer; E J Lee; T Tomiyasu; P H Wiernik; J R Testa
Journal:  Blood       Date:  1989-01       Impact factor: 22.113

Review 2.  Childhood monosomy 7: epidemiology, biology, and mechanistic implications.

Authors:  S Luna-Fineman; K M Shannon; B J Lange
Journal:  Blood       Date:  1995-04-15       Impact factor: 22.113

3.  Lineage switch in childhood leukemia with monosomy 7 and reverse of lineage switch in severe combined immunodeficient mice.

Authors:  H Fujisaki; J Hara; K Takai; K Nakanishi; Y Matsuda; H Ohta; Y Osugi; S Tokimasa; M Taniike; G Hosoi; M Sako; S Okada
Journal:  Exp Hematol       Date:  1999-05       Impact factor: 3.084

4.  Juvenile monosomy 7 syndrome: evidence that the disease originates in a pluripotent hemopoietic stem cell.

Authors:  D E Hogge; K M Shannon; D K Kalousek; S Schonberg; V Schaffner; S Zoger; C J Eaves; A C Eaves
Journal:  Leuk Res       Date:  1987       Impact factor: 3.156

5.  Monosomy 7 in multilineage and acute lymphoblastic leukaemia.

Authors:  E Paietta; R Gucalp; P H Wiernik
Journal:  Br J Haematol       Date:  1991-10       Impact factor: 6.998

6.  Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults.

Authors:  M M de Planque; H C Kluin-Nelemans; H J van Krieken; P M Kluin; A Brand; G C Beverstock; R Willemze; J J van Rood
Journal:  Br J Haematol       Date:  1988-09       Impact factor: 6.998

7.  Chromosomal loss and deletion are the most common mechanisms for loss of heterozygosity from chromosomes 5 and 7 in malignant myeloid disorders.

Authors:  W L Neuman; C M Rubin; R B Rios; R A Larson; M M Le Beau; J D Rowley; J W Vardiman; J L Schwartz; R A Farber
Journal:  Blood       Date:  1992-03-15       Impact factor: 22.113

8.  Chromosome pattern, occupation, and clinical features in patients with acute nonlymphocytic leukemia.

Authors:  F Mitelman; P G Nilsson; L Brandt; G Alimena; R Gastaldi; B Dallapiccola
Journal:  Cancer Genet Cytogenet       Date:  1981-11

9.  Monosomy 7 in childhood: a myeloproliferative disorder.

Authors:  C A Sieff; J M Chessells; B A Harvey; V J Pickthall; S D Lawler
Journal:  Br J Haematol       Date:  1981-10       Impact factor: 6.998

10.  Mutations of the ras proto-oncogenes in childhood monosomy 7.

Authors:  A Neubauer; K Shannon; E Liu
Journal:  Blood       Date:  1991-02-01       Impact factor: 22.113

View more
  1 in total

1.  Reduced DOCK4 expression leads to erythroid dysplasia in myelodysplastic syndromes.

Authors:  Sriram Sundaravel; Ryan Duggan; Tushar Bhagat; David L Ebenezer; Hui Liu; Yiting Yu; Matthias Bartenstein; Madhu Unnikrishnan; Subhradip Karmakar; Ting-Chun Liu; Ingrid Torregroza; Thomas Quenon; John Anastasi; Kathy L McGraw; Andrea Pellagatti; Jacqueline Boultwood; Vijay Yajnik; Andrew Artz; Michelle M Le Beau; Ulrich Steidl; Alan F List; Todd Evans; Amit Verma; Amittha Wickrema
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-02       Impact factor: 11.205

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.